ANSELL (UNSP.ADRS)/4 (PD1) - Total Liabilities

Latest as of June 2025: €1.34 Billion EUR ≈ $1.57 Billion USD

Based on the latest financial reports, ANSELL (UNSP.ADRS)/4 (PD1) has total liabilities worth €1.34 Billion EUR (≈ $1.57 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PD1 net assets growth trend to track the company's year-over-year net asset growth rate.

ANSELL (UNSP.ADRS)/4 - Total Liabilities Trend (2022–2025)

This chart illustrates how ANSELL (UNSP.ADRS)/4's total liabilities have evolved over time, based on quarterly financial data.

ANSELL (UNSP.ADRS)/4 Competitors by Total Liabilities

The table below lists competitors of ANSELL (UNSP.ADRS)/4 ranked by their total liabilities.

Company Country Total Liabilities
Shinsegae
KO:004170
Korea ₩8.83 Trillion
Tongding Interconnection Information
SHE:002491
China CN¥3.40 Billion
Espressif Systems Shanghai Co Ltd
SHG:688018
China CN¥635.23 Million
Unibel S.A
PA:UNBL
France €2.65 Billion
Kodiak Sciences Inc
NASDAQ:KOD
USA $193.91 Million
Lennar Corporation
NYSE:LEN-B
USA $11.18 Billion
Shandong Dongyue Organosilicon Mat
SHE:300821
China CN¥1.14 Billion
SolarEdge Technologies Inc
NASDAQ:SEDG
USA $1.85 Billion

Liability Composition Analysis (2022–2025)

This chart breaks down ANSELL (UNSP.ADRS)/4's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PD1 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ANSELL (UNSP.ADRS)/4's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ANSELL (UNSP.ADRS)/4 (2022–2025)

The table below shows the annual total liabilities of ANSELL (UNSP.ADRS)/4 from 2022 to 2025.

Year Total Liabilities Change
2025-06-30 €1.34 Billion
≈ $1.57 Billion
+0.55%
2024-06-30 €1.33 Billion
≈ $1.56 Billion
+45.59%
2023-06-30 €915.20 Million
≈ $1.07 Billion
-3.62%
2022-06-30 €949.60 Million
≈ $1.11 Billion
--

About ANSELL (UNSP.ADRS)/4

F:PD1 Germany Medical Instruments & Supplies
Market Cap
$2.51 Billion
€2.15 Billion EUR
Market Cap Rank
#5362 Global
#865 in Germany
Share Price
€59.50
Change (1 day)
-0.83%
52-Week Range
€59.50 - €77.00
All Time High
€93.98
About

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more